Comment
Hillary's History on Rx Price Controls
We may think we know all about Senator Clinton’s view on drug and price controls, but to figure out when and how she arrived at her current position, Tom Norton looks at how her stance has evolved over the last 22 years
...Read more |
 |
Comment
Will Hillary's Prescription Plan Hinder R&D
Democratic candidate Hillary Clinton’s Prescription Drug Plan is meant to benefit patients. But, asks Moe Alsumidaie, will it be good for advancing novel therapies, and will it benefit R&D organizations?
...Read more |
 |
IP
Knowledge is Value: Navigating Biopharma's New IP Terrain
Driven by knowledge advances and the importance of a more collaborative commercial model, intellectual property has morphed from an arcane, specialized function dominated by technicians to a showcase strategic priority of the “c-suite.” William Looney reports
...Read more |
 |
Event
ThinkLive: The Importance of Forward-Facing Collaboration
AmerisourceBergen convened a crowd of more than 500 industry executives from seven countries for its ThinkLive2015 annual summit last week. The theme was the vital importance of forward-facing collaboration with pharma and others to address changing market conditions in health care
...Read more |
PDMA regulations require sample inventory counts to be conducted on a regular basis with all sales representatives. While traditionally documented on paper (and later input into a computer system), technological advances have allowed this information to be captured electronically at the inventory site, providing many benefits to pharmaceutical companies.
 Learn more about the benefits.
|
Event
Prix Galien to Highlight Industry Positives
The Prix Galien forum and awards will once again convene some of the industry’s biggest personalities for a day of accolades and introspection on October 27th. In a season full of negativity and criticism, the industry will pause to honor some of its top achievements before bracing itself for a combative political year. Casey McDonald previews this year’s event
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
 |
 //BioBlast Pharma (New Haven, CT) appointed Theresa (Terri) Stevens to the newly created position of Chief Corporate Development Officer (CCDO).//CymaBay Therapeutics (Newark, CA) announced that Robert J. Wills, Ph.D., a member of the Board of Directors since March 2015, has been appointed Chairman of the Board of Directors. Dr. Wills replaces retiring Chairman, Louis G. Lange, M.D., Ph.D.//Caladrius Biosciences (Basking Ridge, NJ) announced the promotions of Joseph Talamo from Vice President, Corporate Controller and Chief Accounting Officer to Chief Financial Officer and Todd Girolamo from Vice President, Legal to General Counsel. The company also announced that Robert S. Vaters has resigned from its board of directors.//SCYNEXIS (Jersey City, NJ) appointed Rajeshwar Motheram, Ph.D., as Vice President, Pharmaceutical Development.// |
|
How intelligent is your multichannel strategy?
Live webinar: Wed., Nov. 4, 2015 at 11:00 AM EST
Join Drew Romes and Kyu Om from Quintiles, as the key steps to enable a successful implementation of truly integrated multichannel engagement programs as part of your marketing activities.
 Register for free
|
|
Ready, Set, Launch!
Launch Planning Insights
LIVE WEBCAST: Thursday, October 29, 2015 at 11 am EST
 Register for free
|
|
|
